Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas

Clinical Cancer Research

Volumn 7, Issue 3, 2001, Pages 594-599

  Matsumura, T ^a   Makino, R ^a   Mitamura, K ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UVOMORULIN;

ARTICLE; CELL ADHESION; CHROMOSOME 16Q; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 16; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MODELS, GENETIC; PROMOTER REGIONS (GENETICS); RIBONUCLEASES; RNA, MESSENGER;

EID: 0034905286     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rising incidence of hepatocellular carcinoma in the United States
2. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
3. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
4. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer
5. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
6. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma
7. Detection of mutation of the p53 gene with high sensitivity by fluorescence-based PCR-SSCP analysis using low-pH buffer and an automated DNA sequencer in a large number of DNA samples
8. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
9. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
10. Cadherin cell adhesion receptors as a morphogenetic regulator
11. E-cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion
12. E-cadherin germline mutations in familial gastric cancer
13. E-cadherin gene mutations in human gastric carcinoma cell lines
14. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
15. E-cadherin is a tumour/ invasion suppressor gene mutated in human lobular breast cancers
16. E-cadherins expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
17. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas
18. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
19. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas
20. Mutations of the human E-cadherin (CDH1) gene
21. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities
22. The 1993-94 Genethon human genetic linkage map
23. A comprehensive genetic map of the human genome based on 5,264 microsatellites
24. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: Characterization of the human E-cadherin gene promoter
25. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
26. Allelic loss of chromosomes 16q and 10q in human prostate cancer
27. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer
28. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
29. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma
30. Allelotype study of primary hepatocellular carcinoma
31. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: Association with elevated α-fetoprotein production
32. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
33. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer
34. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
35. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma
36. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts
37. Regulation of E-cadherin/catenin association by tyrosine phosphorylation